| Application no. and date | 18704639.6 (espacenet) (Federated) (European Patent Register), 20180105 | | Patent/reg. no. and date | DK/EP 3565586, 20251008 | | Publication date | 20191113 | | Priority no. and date | US 201762443519 P, 20170106, US 201762466921 P, 20170303, US 201762504385 P, 20170510 | | EP pub. no. and date |
EP 3565586 20191113 | | Effective date | | | Applicant/owner | Iovance Biotherapeutics, Inc., 825 Industrial Road
Suite 100
San Carlos, CA 94070, US | | Applicant ref. no. | | | Inventor | LOTZE, Michael, T., 5134 Westminster Place
Pittsburgh, PA 15232, US,
RITTHIPICHAI, Krit, 14605 N 42nd Street
Apt. 60
Tampa,FL 33613, US | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C12N 5/0783 (2010.01) | | Title | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF | | Int. application no. | US2018012610 | | Int. publication no. | WO2018129336 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
